Interval Between Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma: Does Delayed Surgery Impact Outcome?

By Chiu Chien-Hong   Chao Yin-Kai   Chang Hsien-Kun   Tseng Chen-Kan   Chan Sheng-Chieh   Liu Yun-Hen   Chen Wei-Hsun  

Annals of Surgical Oncology, Vol. 20, Iss. 13, 2013-12 ,pp. : 4245-4251

Springer Publishing Company

Access to resources Recommend Favorite

Rad51 Expression Is a Useful Predictive Factor for the Efficacy of Neoadjuvant Chemoradiotherapy in Squamous Cell Carcinoma of the Esophagus

By Nakanoko Tomonori   Saeki Hiroshi   Morita Masaru   Nakashima Yuichiro   Ando Koji   Oki Eiji   Ohga Takefumi   Kakeji Yoshihiro   Toh Yasushi   Maehara Yoshihiko  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 597-604

Springer Publishing Company

Access to resources Recommend Favorite

Early evaluation of the apoptotic index ratio is useful in predicting the efficacy of chemoradiotherapy in esophageal squamous cell carcinoma

By              

Oncology Letters, Vol. 3, Iss. 2, 2012-01 ,pp. : 287-292

Spandidos Publications

Access to resources Recommend Favorite

Trimodality therapy of esophagectomy plus neoadjuvant chemoradiotherapy improves the survival of clinical stage II/III esophageal squamous cell carcinoma patients

By                  

Oncology Reports, Vol. 28, Iss. 2, 2012-01 ,pp. : 446-452

Spandidos Publications

Access to resources Recommend Favorite

Neoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva

By                  

Oncology Letters, Vol. 4, Iss. 4, 2012-01 ,pp. : 719-722

Spandidos Publications

Access to resources Recommend Favorite